Blood Pressure
"The study.. is a follow-up analysis of the Systolic Blood Pressure Intervention Trial (SPRINT), a multicenter clinical trial that compared intensive systolic blood pressure control (target less than 120 mm Hg) versus standard control (target less than 140 mm Hg). SPRINT enrolled participants aged 50 or older with hypertension and without diabetes or a history of stroke."
"At age 50 years, the estimated residual survival was 37.3 years with intensive [BP lowering] treatment and 34.4 years with standard treatment (difference, 2.9 years [95% CI, 0.9-5.0 years];"
"..Patients receiving intensive blood pressure treatment showed reduced white matter lesions in frontal and posterior deep white matter, and improved blood flow, indicating better overall brain health.. White matter lesions are among the changes that can be associated with Alzheimer's disease, non–Alzheimer's disease cognitive impairment and advanced brain aging."
1
Paper · JAMA CardiologyJAMA Cardiology articlejamanetwork.com2
Paper · JAMA Network OpenJAMA Network Open articlejamanetwork.com



